Featured Speakers

Prof Beverley Hunt OBE

Professor Beverley Hunt OBE

Founder of Thrombosis UK and Professor of Haemostasis & Thrombosis, Guy's & St Thomas's Hospital, London.

Professor Beverley Hunt OBE is Professor of thrombosis and haemostasis at King's College and Guy's & St Thomas's, London and is a consultant in the departments of haematology & pathology. She is a national and international expert in thrombosis and acquired bleeding disorders.

She has sat on multiple national and international guideline writing groups, including NICE has extensive clinical experience of thrombotic and acquired bleeding disorders and runs a very active research group with over 400 peer-reviewed publications to her name.

Prof Hunt is chair of the steering committee of World Thrombosis Day.

Helen Williams

Helen Williams FFRPS, FRPharmS

Consultant Pharmacist for Cardiovascular Disease, South East London CCG and UCLPartners
National Specialty Adviser for CVD Prevention, NHSE and I

Email: helen.williams11@nhs.net

Helen is the National Speciality Adviser for CVD Prevention at NHS England and is working on delivery of the national CVD ambitions for AF, Blood Pressure and Cholesterol in the NHS Long Term Plan. Helen has worked as a CVD specialist for more than 25 years across all care settings. She was clinical adviser to the national AF programme and developed the pharmacist-led virtual clinic model to optimise uptake of anticoagulation in AF, which has now been spread nationally. Helen has recently been appointed as one of the long term conditions lead for South East London Integrated Care System and is also working at UCLPartners on the implementation of proactive care frameworks for long-term conditions to support primary care in the post COVID-19 environment.

Dr Raza Alikhan

Dr Raza Alikhan

Consultant Haematologist, Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff

Dr Raza Alikhan is a consultant haematologist at the Haemophilia and Thrombosis Centre, University Hospital of Wales and member of the British Society for Haematology (BSH) Thrombosis and Haemostasis Task Force and Guideline Committee and Chair of the BSH Cancer Associated Thrombosis Guideline Writing Group. He is a Fellow of the Royal College of Pathologists and a Member of the Royal College of Physicians having received his medical degree from the University of London and completed postgraduate studies in London and Oxford. He defended his doctoral thesis on venous thromboembolism and prophylaxis in medical patients and was the UK National Lead Investigator for the rivaroxaban medical thromboprophylaxis study (MARINER). He is he UK Chief Investigator for both the apixaban treatment of cancer associated thrombosis study (CARAVAGGIO) and the apixaban length of stay pulmonary embolism study (ALPHA-PE).

Dr Alikhan has been involved in phase II–IV anticoagulant clinical trials since the late 90s. His current research interests include the identification of risk factors and outcomes associated with anticoagulation related bleeding. He is the UK Chief Investigator for the andexanet alfa DOAC and LMWH antidote study (ANNEXA-4) and is a member of the steering committee for the oral anticoagulant agent associated bleeding events reporting system (ORANGE) and the secure anonymised information linkage bleeding risk evaluation (SABRE) study. He has authored more than 100 conference abstracts, peer-reviewed papers and book chapters on thrombosis and haemostasis.

Prof Simon Noble

Professor Simon Noble

Medical Director of Thrombosis UK and Marie Curie Professor of Supportive & Palliative Medicine in Cardiff University and honorary consultant Royal Gwent Hospital Newport.

Dr Noble's main research interests are in the management of venous thromboembolism in advanced cancer, the anticancer effects of heparins and the quality of life associated with VTE. He set up the South East Wales Cancer Associated Thrombosis Service which sees 500 new cases per year.

He is chief investigator on the International PELICAN study which explored the impact of cancer associated thrombosis (CAT) on patients in different countries and healthcare settings.

He has sat on several clinical guideline groups including NICE CG89, ASH CAT guidelines and several ISTH guidance documents. He is Medical Director of Thrombosis UK and medical advisor to Anticoagulation UK. He has published over one hundred original papers, twenty seven chapters and six books. His interests include hill walking, travel and hip-hop.



October 18, 2022 09:00

Living with the consequences of VITT: one year post vaccination

Vaccine-immune thrombocytopenia and thrombosis (VITT)

Prof Paul Bennett

October 18, 2022 10:00

The management of pulmonary embolism

  • The management of low-risk PE
  • Intermediate & high-risk PE - how to use your local PELT (pulmonary embolism lysis team)
  • The ins and outs of substituting urokinase for t-PA in lysis regimes.
  • The place for endovascular mechanical thrombectomy in PE

Prof Beverley Hunt OBE

Victoria Collings

Dr Raza Alikhan

Dr Narayan Karunanithy

Dr Karen Breen

October 18, 2022 12:10

An Update on the position of Hospitalised Acquired Thrombosis in Wales

Andrea Croft

October 18, 2022 13:00

The challenge of effective communication with VTE patients

A round table discussion inviting Q&As

Prof Paul Bennett

Hannah Eden

Jackie Merchant

Sinead Duffy

Dr Will Lester

October 18, 2022 14:00

Prevention of vEnous Thromboembolism in low-risk Surgical patients (PETS Trial)

With continued discussion and recent research evidence, this session will examine the benefit of graduated compression stockings in the Prevention of vEnous Thromboembolism in low-risk Surgical patients: a multicentre cluster randomised control trial (PETS)

Sarah Whittley

October 18, 2022 14:45

BMS-Pfizer Alliance Sponsored Symposium

Dr Ander Cohen

Dr Satarupa Choudhuri

Dr Will Lester

October 19, 2022 09:00

Cardinal Health Sponsored Symposium

VTE risks during C-sections, and the importance of timely prophylaxis

Prof Catherine Nelson-Piercy

October 19, 2022 10:10

UKCPA Symposium Peri-operative management of anticoagulation

Katherine Stirling

Rosalind Byrne

Stephane Jaglin

Dr Alice Burridge

October 19, 2022 11:15

BMS-Pfizer Alliance Sponsored Symposium

Dr Ander Cohen

Dr Satarupa Choudhuri

October 19, 2022 12:00

Cancer Associated VTE

Understanding and implementing risk, changes to practice, therapy options and learning

Prof Simon Noble

Huw Rowswell

Dr Raza Alikhan

October 19, 2022 13:05

LumiraDx Sponsored Symposium

Improving Patient Care through Innovative Thrombosis and Haemostasis Testing: The Need for Point of Care D-Dimer Testing

Dr Matthew Fay

October 19, 2022 14:00

Frontiers in thrombosis research

New advances in understanding the pathogenesis of HIT and VITT Advances in fibrinolysis Thrombogenomics

Prof Beverley Hunt OBE

Prof Cheng-Hock Toh

Prof Nicola Mutch

Dr Suthesh Sivapalaratnam, MD PhD MRCP (London) FRCPath

October 19, 2022 15:45

Primary Care Cardiovascular Society Symposium

FAQs – Anticoagulation in Primary Care for Stroke Prevention in Atrial Fibrillation

GP, Dr Jim Moore, President of the Primary Care Cardiovascular Society will discuss and welcome FAQs on anticoagulation in primary care for stroke prevention in atrial fibrillation.

The Primary Care Cardiovascular Society (PCCS) is a multi-disciplinary society reflecting the ideas and opinions of primary care healthcare professionals throughout the UK involved in managing cardiovascular patient care and improving cardiovascular health. We are committed to promoting best practice in primary care cardiovascular health through education, training, and service development. 

Representing primary care cardiovascular health needs at policy level, we support the development of primary health care professionals in cardiovascular medicine and facilitate and lead primary care cardiovascular research.

Dr Jim Moore

October 20, 2022 09:00

VTE National Nursing & Midwifery Symposium

Process and Progress on VTE Prevention

  • VTE Patient Information Animation
  • Patient Information for People with Learning Difficulties
  • The process of creating a VTE staff education video
  • Hormone and transgender thrombosis risk
  • A new strategy for non-pharmacological VTE prevention – Actions taken at Guy’s and St Thomas’ NHS Foundation Trust

This session is aimed at hospital and community nurses with an interest in VTE, through short presentations, this symposium is designed to sow the seeds that result in innovation and progress in the delivery of thrombosis care.  The session will focus on specific issues such as patient information, staff education and use of anti-embolism stockings to give nurses the inspiration, motivation and tools they need to continue to advance thrombosis patient care.

Becs Walsh

Tinaa Simmons-Lindill

Sarah Havord

Huw Rowswell

Anthony Hackett

Ellen Quinney

October 20, 2022 10:30

Where is warfarin in a world of DOACs?

Delivered via a panel, this session will consider the challenges now faced in maintaining high quality, expert warfarin services, for an increasingly complex cohort of patients and include:

  • How is warfarin going to be provided when 90% of those anticoagulated are on DOACs?
  • Will services maintain local hubs? 
  • Will the professional competencies be maintained? 
  • Who is watching for the change in provision or the consequences of poor care?
  • What does this mean to patient safety and patient experience?

The session will specifically highlight the issues that has significant impact on those with or managing patients with a history of thrombosis due to complex coagulopathies, antiphospholipid syndrome as well as those with mechanical valves, often requiring high range INR and bridging services.

Dr Matthew Fay

Helen Williams, FFRPS, FRPharmS

Hayley Flavell

October 20, 2022 12:00

Getting it right: Case Studies in prevention and early diagnosis of VTE

Dr Gillian Lowe

Dr Matthew Fay

Prof Paul Bennett

Andrew Morris

Hannah Eden

Dr Daniel Horner

October 20, 2022 14:00

geko™ device – G&N Sponsored Symposium

The use of the geko™ device (a neuromuscular electrostimulation device) for the prevention of venous thromboembolism in patients with acute stroke

Dr Indira Natarajan

October 20, 2022 15:00

AstraZeneca Sponsored Symposium

Practical Application of DOAC Reversal in the Emergency Setting

Dr Raza Alikhan

About Us

Let’s Talk Clots 2022 virtual conference:

Thrombosis UK welcomes you to our third virtual conference hosted in support of World Thrombosis Day (WTD) 2022.

Let’s Talk Clots conference welcomes all health care and allied professionals working to improve prevention, diagnosis and management of patients at risk of or diagnosed with venous thromboembolism (VTE).

With free registration and accredited learning, the “Let’s Talk Clots’ conference will provide opportunity to consider:

  • Evidence to inform improvement and outcomes,
  • National guidelines supporting best practise, and
  • Pathways for effective implementation.

Accredited sessions are delivered live inviting:

  • Questions
  • discussion and
  • opportunity to share

With the added benefit that ‘catch-up’ / ‘view again’ recordings of each session are uploaded to the platform within 24 hours of the live event and to registered attendees accessible 24/7 until 30 November 2022.

Both live and recorded sessions provide CPD credits.

The new 2022 exciting new platform also offers a main auditorium, exhibition room, networking areas and links to professional bodies and organisations which can offer support, resources, networking and sign posting.

Welcome to Let’s Talk Clots 2022!

About Thrombosis UK

Thrombosis UK is a registered charity working to increase awareness, support research and extend understanding through education and the sharing of information to improve care for all those affected by thrombosis.

Our priority is for everyone to: KNOW the risks, signs and symptoms of venous thromboembolism (VTE) and to support research to extend UNDERSTANDING



The Let’s Talk Clots 2022 conference has been developed by Thrombosis UK.

Sponsoring companies have had no input into the conference agenda, speaker selection or presentations with the exception of sponsored symposia sessions, for which the respective sponsoring company is fully responsible.

AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence. Except for the AstraZeneca sponsored symposia presentation.


Frequently Asked Questions

The Let’s Talk Clots’22 virtual conference is open to all healthcare and allied professionals. Due to health products (therapy and device) regulations, members of the public are unable to register.
Select the ‘Register Now’ button on the HOME page of the Let’s Talk Clots ‘22 website to secure your place.
You will receive an email to confirm your registration has been submitted, and once verified, a second email will confirm when you have been successfully registered.
All attendees need to register first to access the virtual conference. Once your registration has been successfully confirmed, you will be able to access the platform from Tuesday 18 October 2022 by clicking on the ‘Click Here to Log In’ button on the Home page. This will take you into the lobby of the conference where you will then be able to access all areas.
No! Your single registration will allow you access to all agenda sessions, catch-up recordings, pre-records, the exhibition area, lobby, and networking rooms.
No! Thrombosis UK offer the Let’s Talk Clots’22 accredited conference free of charge – we want everyone to ‘know thrombosis’ and understand the optimum management in prevention, detection, care, and on-going management.
The conference is applying for CPD points from the Royal College Pathologists. These will be confirmed once the agenda is finalised. CPD credits will be awarded to registered attendees who attend live sessions or view the catch-up recordings hosted within the platform and pre-recorded meetings.
After registering as an attendee, you only need your email address to log-in to the conference.
Log-in to the Let’s Talk Clots Conference and this will take you into the ‘Lobby’ area.
To view sessions, click on ‘Auditorium’. You will then be able to select whether you watch a ‘live’ session taking place at that time or view recordings of sessions already presented during the conference.
Yes! The Let’s Talk Clots’22 platform will remain open 24/7 to registered attendees until 30 November 2022. During this time, you will be able to visit the platform and watch the catch-up recordings to secure CPD credits. The exhibition area will also remain open with access to informational resources.
After 30 November, most of the recordings (not sponsored symposia) will be uploaded to the Thrombosis UK website and available with open access however they will no longer carry CPD accreditation.
The Let’s Talk Clots platform will recognise when you visit and view any session (live or recorded). When the platform closes (30 November 2022), CPD certificates will be sent to each attendee in line with their attendance.
If you are a researcher, healthcare professional or lead in a professional body and would like to would like to discuss opportunities to present at the conference or have an exhibition booth, please contact jo@thrombosisuk.org
Yes! Let’s Talk Clots'22 conference has a variety of sponsorship opportunities open to companies. To discuss and find out more please email jo@thrombosisuk.org
Thrombosis UK – a registered UK charity!
You can contact us by emailing jo@thrombosisuk.org, or visit the charity’s website where there is a wealth of information and free resources.
Recordings from past conferences hosted by Thrombosis UK are also available to view.